1. Home
  2. DNOW vs GPCR Comparison

DNOW vs GPCR Comparison

Compare DNOW & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NOW Inc.

DNOW

NOW Inc.

HOLD

Current Price

$13.23

Market Cap

2.4B

Sector

Industrials

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$37.35

Market Cap

2.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNOW
GPCR
Founded
1862
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.8B
IPO Year
2014
2023

Fundamental Metrics

Financial Performance
Metric
DNOW
GPCR
Price
$13.23
$37.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
12
Target Price
$16.67
$103.17
AVG Volume (30 Days)
3.1M
754.9K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,648,000,000.00
N/A
Revenue This Year
$69.47
N/A
Revenue Next Year
$8.01
N/A
P/E Ratio
N/A
N/A
Revenue Growth
25.68
N/A
52 Week Low
$10.94
$15.80
52 Week High
$17.26
$94.90

Technical Indicators

Market Signals
Indicator
DNOW
GPCR
Relative Strength Index (RSI) 56.12 32.50
Support Level $13.05 $30.82
Resistance Level $13.96 $40.29
Average True Range (ATR) 0.43 2.15
MACD -0.04 0.04
Stochastic Oscillator 48.09 14.44

Price Performance

Historical Comparison
DNOW
GPCR

About DNOW NOW Inc.

Dnow Inc is a provider of energy and industrial solutions and a distributor of pipe, valves, and fittings (PVF) and pumps, as well as fabrication, assembly, and testing of process and production equipment. It provides a broad mix of products required to build and maintain essential infrastructure and operating equipment across upstream, midstream, gas utilities, downstream, energy transition, and industrial markets, along with value-added supply chain solutions and technical product expertise supported by digital offerings through its DigitalNOW and MRCGO e-commerce platforms. The company operates mainly under the DNOW and MRC brands and has three reportable segments: the United States, which generates the majority of revenue, Canada, and International.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: